The morphological basis for altered endothelial permeability in artherosclerosis.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000936:Antigen-Antibody Complex; D001158:Arteries / Q000293:injuries / Q000503:physiopathology*; D001161:Arteriosclerosis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D001679:Biogenic Amines / Q000494:pharmacology; D002248:Carbon Monoxide / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004727:Endothelium / Q000503:physiopathology; D005227:Fatty Acids / Q000097:blood; D006973:Hypertension / Q000150:complications; D012212:Rheology
D000936:Antigen-Antibody Complex; D001679:Biogenic Amines; D005227:Fatty Acids; D000804:Angiotensin II; D002248:Carbon Monoxide; D002784:Cholesterol